KDR and squamous cell carcinoma: On the other hand, Butkiewicz et al. [57] analyzed 422 patients with squamous cell carcinoma of the head and neck undergoing radiotherapy and concluded that VEGFR2 rs1870377 TT is a significant borderline risk factor for lower local recurrence and an independent predictor of poor prognosis.